Cancer Research (Q4) · Cell Biology (Q4)
| ISSN | 26673940 |
|---|---|
| Country | United States |
| Subject Areas | Cancer Research (Q4) · Cell Biology (Q4) |
| Publication Type | Elsevier Inc. |
| Active Years | Journals |
| JIF 2022–2023 | 2.000 |
2021-2023
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2023 | 2.247 | 2.247 | 2.247 |
| 2022 | 1.235 | 1.235 | 1.235 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.376 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 8.000 |